Induction therapy with antithymocyte serum (NATS) increases graft survival and function in kidneys with initial poor function.
| Autor: | Goldman MH; Department of Surgery, University of Tennessee Medical Center-Knoxville., Regester RF, Freeman MB, Tyler B, Tyler JD |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Transplantation proceedings [Transplant Proc] 1991 Apr; Vol. 23 (2), pp. 1753-4. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|